SCOPUS 정보 검색 플랫폼

Morbidity and Mortality Weekly Report

Volumn 65, Issue 27, 2016, Pages 696-697

Meningococcal disease in an international traveler on eculizumab therapy — United States, 2015

(5) Applegate, Allen O a Fong, Vanessa C a Tardivel, Kara a Lippold, Susan A a Zarate, Sheilah b

a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES (United States)

b SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECULIZUMAB; MONOCLONAL ANTIBODY;

ADULT; AIRCRAFT; CASE REPORT; CONTACT EXAMINATION; GERMANY; HUMAN; ISOLATION AND PURIFICATION; MALE; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS; TRAVEL; UNITED STATES;

ADULT; AIRCRAFT; ANTIBODIES, MONOCLONAL, HUMANIZED; CONTACT TRACING; GERMANY; HUMANS; MALE; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS, SEROGROUP A; TRAVEL; UNITED STATES;

EID: 84978698052 PISSN: 01492195 EISSN: 1545861X Source Type: Journal
DOI: 10.15585/mmwr.mm6527a3 Document Type: Note

Times cited : (10)

References (6)

1
- 52949136616
- FDA report: Eculizumab (Soliris) for the treatment of patients with paroxysmal nocturnal hemoglobinuria
- Dmytrijuk A, Robie-Suh K, Cohen MH, Rieves D, Weiss K, Pazdur R. FDA report: eculizumab (Soliris) for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Oncologist 2008;13:993-1000. http://dx.doi.org/10.1634/theoncologist.2008-0086
- (2008) Oncologist , vol.13 , pp. 993-1000
- Dmytrijuk, A.¹ Robie-Suh, K.² Cohen, M.H.³ Rieves, D.⁴ Weiss, K.⁵ Pazdur, R.⁶

2
- 84879121370
- Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria
- Hillmen P, Muus P, Röth A, et al. Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 2013;162:62-73. http://dx.doi.org/10.1111/bjh.12347
- (2013) Br J Haematol , vol.162 , pp. 62-73
- Hillmen, P.¹ Muus, P.² Röth, A.³

3
- 84958283629
- Atlanta, GA: US Department of Health and Human Services, CDC
- CDC. Meningococcal: who needs to be vaccinated? Atlanta, GA: US Department of Health and Human Services, CDC; 2015. http://www.cdc.gov/vaccines/vpd-vac/mening/who-vaccinate.htm
- (2015) Meningococcal: Who Needs to Be Vaccinated?

4
- 84978721006
- Atlanta, GA: US Department of Health and Human Services, CDC
- CDC. Prevention and control of meningococcal disease: recommendations of the advisory committee on immunization practices (ACIP). Atlanta, GA: US Department of Health and Human Services, CDC; 2015. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6202a1.htm
- (2015) Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

5
- 27744517019
- Meningococcal disease—probable transmission during an international flight
- O’Connor BA, Chant KG, Binotto E, Maidment CA, Maywood P, McAnulty JM. Meningococcal disease—probable transmission during an international flight. Commun Dis Intell Q Rep 2005;29:312-4.
- (2005) Commun Dis Intell Q Rep , vol.29 , pp. 312-314
- O’Connor, B.A.¹ Chant, K.G.² Binotto, E.³ Maidment, C.A.⁴ Maywood, P.⁵ McAnulty, J.M.⁶

6
- 33745955755
- Bacterial meningitis exposure during an international flight: Lessons for communicable pathogens
- Riley LK. Bacterial meningitis exposure during an international flight: lessons for communicable pathogens. Aviat Space Environ Med 2006;77:758-60.
- (2006) Aviat Space Environ Med , vol.77 , pp. 758-760
- Riley, L.K.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.